Dr. Heidi Overton Tapped to Lead FDA
President Donald Trump has selected Dr. Heidi Overton, a top White House aide and deputy director of the White House Domestic Policy Council, to lead the Food and Drug Administration (FDA). Overton, a medical doctor, has been involved in several…
Philadelphia, PA, August 19, 2026 —
President Donald Trump has announced his intention to nominate Dr. Heidi Overton to lead the Food and Drug Administration (FDA). Dr. Overton currently serves as a deputy director of the White House Domestic Policy Council and is described as a trusted aide within the administration.
A medical doctor by training, Dr. Overton has been engaged in various health-related initiatives during the Trump presidency. Her appointment to lead the FDA is subject to confirmation by the U.S. Senate.
Should she be confirmed, Dr. Overton would be tasked with navigating a complex landscape of competing interests. These priorities are understood to include those of President Trump, the traditional interests of the Republican party, and the portfolio of Health Secretary Robert F. Kennedy Jr.
The nomination comes as the FDA plays a critical role in regulating food, drugs, and medical devices. The agency’s leadership often faces scrutiny over public health policies, drug approvals, and food safety standards.
Further details regarding Dr. Overton’s specific qualifications for the role or the timeline for her Senate confirmation hearing were not immediately available.
Story summarized from the original created by The Associated Press on www.inquirer.com, see more information here.
